• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Delphian 淋巴结转移对甲状腺癌的预测价值。

Predictive Value of Delphian Lymph Node Metastasis in the Thyroid Cancer.

机构信息

Department of Otolaryngology Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Department of Otolaryngology Head and Neck Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

出版信息

Laryngoscope. 2021 Sep;131(9):1990-1996. doi: 10.1002/lary.29426. Epub 2021 Jan 25.

DOI:10.1002/lary.29426
PMID:33493364
Abstract

OBJECTIVE/HYPOTHESIS: To evaluate the diagnostic accuracy of Delphian lymph node (DLN) metastasis for the prediction of central lymph node (CLN) metastasis and lateral lymph node (LLN) metastasis.

METHODS

Two authors independently reviewed the six databases (Cochrane database, Embase, Google Scholar, PubMed, SCOPUS, and Web of Science). Four parameters were extracted from each study: true positive, true negative, false positive, and false negative. The quality of the methodology was evaluated using the Quality Assessment of Diagnostic Accuracy Studies ver. 2 tool.

RESULTS

The diagnostic odds ratio of DLN in CLN metastasis was 8.859 (95% confidence interval [CI], 4.419; 16.578). The area under the summary receiver operating characteristic curve was 0.748. The diagnostic odds ratio of DLN in LLN metastasis was 7.61 (95% CI, 4.48; 12.94). The area under the summary receiver operating characteristic curve was 0.837. DLN metastasis was moderately predictive of CLN metastasis (sensitivity = 32%, specificity = 95%), LLN metastasis (sensitivity = 52%, specificity = 89%), and contralateral CLN metastasis (sensitivity = 46%, specificity = 85%). DLN metastasis had statistically significant correlation with specific clinicopathological characteristics, including younger age (< 45 years old), bilaterality, capsule invasion, extrathyroidal extension, lymphovascular invasion, male sex, multifocality, and tumor size (> 1 cm).

CONCLUSIONS

The higher specificities of DLN pathology may help predict central and lateral compartment involvement in patients with thyroid cancer.

LEVEL OF EVIDENCE

NA Laryngoscope, 131:1990-1996, 2021.

摘要

目的/假设:评估 Delphian 淋巴结 (DLN) 转移对中央淋巴结 (CLN) 转移和侧方淋巴结 (LLN) 转移预测的诊断准确性。

方法

两位作者独立检索了六个数据库(Cochrane 数据库、Embase、Google Scholar、PubMed、SCOPUS 和 Web of Science)。从每项研究中提取了四个参数:真阳性、真阴性、假阳性和假阴性。使用诊断准确性研究质量评估工具(第 2 版)评估方法学的质量。

结果

DLN 对 CLN 转移的诊断优势比为 8.859(95%置信区间 [CI],4.419;16.578)。汇总受试者工作特征曲线下面积为 0.748。DLN 对 LLN 转移的诊断优势比为 7.61(95% CI,4.48;12.94)。汇总受试者工作特征曲线下面积为 0.837。DLN 转移对 CLN 转移(敏感性为 32%,特异性为 95%)、LLN 转移(敏感性为 52%,特异性为 89%)和对侧 CLN 转移(敏感性为 46%,特异性为 85%)具有中度预测价值。DLN 转移与特定的临床病理特征具有统计学显著相关性,包括年龄较小(<45 岁)、双侧性、包膜侵犯、甲状腺外延伸、淋巴血管侵犯、男性、多灶性和肿瘤大小较大(>1cm)。

结论

DLN 病理学的更高特异性可能有助于预测甲状腺癌患者中央和侧方隔室的受累情况。

证据水平

无。Laryngoscope, 131:1990-1996, 2021.

相似文献

1
Predictive Value of Delphian Lymph Node Metastasis in the Thyroid Cancer.Delphian 淋巴结转移对甲状腺癌的预测价值。
Laryngoscope. 2021 Sep;131(9):1990-1996. doi: 10.1002/lary.29426. Epub 2021 Jan 25.
2
Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.位于甲状腺峡部或上三分之一的乳头状甲状腺癌与Delphian淋巴结转移相关。
World J Surg. 2014 Jun;38(6):1306-11. doi: 10.1007/s00268-013-2406-x.
3
Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.甲状腺乳头状癌 Delphian 淋巴结转移的经验分析。
World J Surg Oncol. 2012 Oct 30;10:226. doi: 10.1186/1477-7819-10-226.
4
Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma.甲状腺乳头状癌 Delphian 淋巴结转移的临床意义。
World J Surg. 2013 Nov;37(11):2594-9. doi: 10.1007/s00268-013-2157-8.
5
Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma.Delphian 淋巴结对甲状腺乳头状癌颈淋巴结转移的预测价值。
Eur J Surg Oncol. 2021 Jul;47(7):1727-1733. doi: 10.1016/j.ejso.2021.02.010. Epub 2021 Feb 18.
6
Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: A systematic review and meta-analysis.应用 Delphian 淋巴结转移预测甲状腺乳头状癌中央区和侧区淋巴结累及:系统评价和荟萃分析。
Clin Endocrinol (Oxf). 2019 Jul;91(1):170-178. doi: 10.1111/cen.13965. Epub 2019 Apr 11.
7
Delphian lymph node metastasis is a novel indicator of tumor aggressiveness and poor prognosis in papillary thyroid cancer.甲状腺乳头状癌中 Delphian 淋巴结转移是肿瘤侵袭性和不良预后的一个新的指标。
J Surg Oncol. 2021 Jun;123(7):1521-1528. doi: 10.1002/jso.26380. Epub 2021 Mar 13.
8
Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer.纳入甲状腺微小乳头状癌 Delphian 淋巴结转移风险特征的临床病理特征的诊断模型。
Front Endocrinol (Lausanne). 2021 Mar 25;12:591015. doi: 10.3389/fendo.2021.591015. eCollection 2021.
9
The Delphian lymph node in thyroid cancer.甲状腺癌中的德尔菲淋巴结。
Ann Surg. 2008 Mar;247(3):477-82. doi: 10.1097/SLA.0b013e31815efdc4.
10
Number of central lymph node metastasis for predicting lateral lymph node metastasis in papillary thyroid microcarcinoma.中央区淋巴结转移数目预测甲状腺微小乳头状癌侧颈区淋巴结转移的研究
Head Neck. 2014 Jan;36(1):101-6. doi: 10.1002/hed.23270. Epub 2013 Jul 30.

引用本文的文献

1
Expression and clinical significance of AUF1 and HIF-1α in papillary thyroid carcinoma.AUF1和HIF-1α在甲状腺乳头状癌中的表达及临床意义
World J Surg Oncol. 2025 Jul 1;23(1):252. doi: 10.1186/s12957-025-03904-0.
2
Explainable machine learning model for predicting paratracheal lymph node metastasis in cN0 papillary thyroid cancer.用于预测 cN0 期甲状腺乳头状癌气管旁淋巴结转移的可解释机器学习模型。
Sci Rep. 2024 Sep 27;14(1):22361. doi: 10.1038/s41598-024-73837-3.
3
Construction of a new tool for predicting cancer-specific survival in papillary thyroid cancer patients who have not received surgery.
构建一种新工具,用于预测未接受手术的甲状腺乳头状癌患者的癌症特异性生存。
Front Endocrinol (Lausanne). 2024 Aug 16;15:1417528. doi: 10.3389/fendo.2024.1417528. eCollection 2024.
4
Development and validation of a nomogram for preoperative prediction of ipsilateral cervical central lymph node metastasis in papillary thyroid cancer: a population-based study.甲状腺乳头状癌同侧颈中央区淋巴结转移术前预测列线图的开发与验证:一项基于人群的研究
Gland Surg. 2024 Apr 29;13(4):528-539. doi: 10.21037/gs-23-478. Epub 2024 Apr 22.
5
Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma.列线图预测甲状腺乳头状癌中央区淋巴结转移。
Clin Exp Metastasis. 2024 Oct;41(5):613-626. doi: 10.1007/s10585-024-10285-3. Epub 2024 Apr 3.
6
Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma.开发和验证一种新的术前临床模型,用于预测肝门周围胆管癌的淋巴结转移。
BMC Cancer. 2024 Mar 4;24(1):297. doi: 10.1186/s12885-024-12068-1.
7
[Analysis of Delphain lymph node detection rate, metastasis rate and risk factors for metastasis in papillary thyroid adenocarcinoma patients].[甲状腺乳头状腺癌患者德尔菲淋巴结检出率、转移率及转移危险因素分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Feb;38(2):150-154;159. doi: 10.13201/j.issn.2096-7993.2024.02.013.
8
Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma.颈前和/或气管前淋巴结转移有助于将单侧甲状腺 T1-2N0 癌灶的甲状腺乳头状癌从低危中识别出来。
Front Endocrinol (Lausanne). 2023 Apr 14;14:1156664. doi: 10.3389/fendo.2023.1156664. eCollection 2023.
9
Relationship between pretracheal and/or prelaryngeal lymph node metastasis and paratracheal and lateral lymph node metastasis of papillary thyroid carcinoma: A meta-analysis.甲状腺乳头状癌气管前和/或喉前淋巴结转移与气管旁及侧方淋巴结转移的关系:一项Meta分析
Front Oncol. 2022 Sep 23;12:950047. doi: 10.3389/fonc.2022.950047. eCollection 2022.
10
Risk Factors for Pulmonary Metastasis in Differentiated Thyroid Carcinoma Patients and the Significance of Changes in Matrix Metalloproteinase 13 and microRNA-142 Levels.分化型甲状腺癌患者肺转移的危险因素及基质金属蛋白酶 13 和 microRNA-142 水平变化的意义。
Contrast Media Mol Imaging. 2022 Sep 5;2022:6820281. doi: 10.1155/2022/6820281. eCollection 2022.